Search Results

There are 5639 results for: content related to: Mrp2 is involved in the efflux and disposition of fosinopril

  1. You have free access to this content
    Fosinopril: Emerging Considerations and Implications for Angiotensin-Converting Enzyme Inhibitor Therapy

    Cardiovascular Drug Reviews

    Volume 16, Issue 4, December 1998, Pages: 319–345, Domenic A. Sica, Todd W. B. Gehr, Nicole Kelleher and Mel Blumenthal

    Version of Record online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1998.tb00362.x

  2. Pharmacokinetics of fosinopril in patients with various degrees of renal function

    Clinical Pharmacology & Therapeutics

    Volume 49, Issue 4, April 1991, Pages: 457–467, Ka Kit Hui, Kenneth L Duchin, Kishin J Kripalani, Diana Chan, Paul K Kramer and Norimoto Yanagawa

    Version of Record online : 28 APR 1991, DOI: 10.1038/clpt.1991.54

  3. Pharmacodynamic effects of dual neutral endopeptidase–angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans

    Clinical Pharmacology & Therapeutics

    Volume 65, Issue 4, April 1999, Pages: 448–459, Christine Massien, Michel Azizi, Thanh-Tam Guyene, Ole Vesterqvist, Bernhard Mangold and Joël Ménard

    Version of Record online : 5 APR 1999, DOI: 10.1016/S0009-9236(99)70140-2

  4. Aggregation behavior of fosinopril sodium — A new angiotensin-converting enzyme inhibitor

    Journal of Pharmaceutical Sciences

    Volume 84, Issue 5, May 1995, Pages: 609–613, Zhulun Wang, Kenneth R. Morris and Benjamin Chu

    Version of Record online : 17 SEP 2006, DOI: 10.1002/jps.2600840516

  5. Pharmacokinetics, Safety, and Pharmacologic Effects of Fosinopril Sodium, an Angiotensin-Converting Enzyme Inhibitor in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 31, Issue 1, January 1991, Pages: 58–64, Dr. Kenneth L. Duchin, Dr. Anothy P. Waclawski, Dr. Jan I. Tu, Dr. James Manning, Dr. May Frantz and Dr. David A. Willard

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1991.tb01887.x

  6. Liquid chromatography/electrospray tandem mass spectrometry method for the quantitation of fosinoprilat in human serum using automated 96-well solid-phase extraction for sample preparation

    Rapid Communications in Mass Spectrometry

    Volume 14, Issue 12, 30 June 2000, Pages: 1023–1028, Mohammed Jemal, Mike Huang, Yan Mao, Daisy Whigan and Alan Schuster

    Version of Record online : 9 JUN 2000, DOI: 10.1002/1097-0231(20000630)14:12<1023::AID-RCM983>3.0.CO;2-K

  7. Comparison of fosinopril and hydrochlorothiazide in patients with mild to moderate hypertension

    Journal of Internal Medicine

    Volume 230, Issue 6, December 1991, Pages: 511–517, T. FORSLUND, P. FRANZÉN and R. BACKMAN

    Version of Record online : 4 AUG 2009, DOI: 10.1111/j.1365-2796.1991.tb00482.x

  8. You have free access to this content
    Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2)

    European Journal of Biochemistry

    Volume 269, Issue 7, April 2002, Pages: 1866–1876, Anne T. Nies, Jörg König, Yunhai Cui, Manuela Brom, Herbert Spring and Dietrich Keppler

    Version of Record online : 3 OCT 2003, DOI: 10.1046/j.1432-1033.2002.02832.x

  9. You have free access to this content
    Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency

    British Journal of Clinical Pharmacology

    Volume 49, Issue 1, January 2000, Pages: 23–31, R. Greenbaum, P. Zucchelli, A. Caspi, H. Nouriel, R. Paz, S. Sclarovsky, P. O'Grady, K.-F. Yee, W.-C. Liao and B. Mangold

    Version of Record online : 31 JAN 2003, DOI: 10.1046/j.1365-2125.2000.00103.x

  10. You have free access to this content
    Fosinopril monotherapy: Relationship between blood pressure reduction and time of administration

    Clinical Cardiology

    Volume 16, Issue 4, April 1993, Pages: 324–330, Neville F. Ford, I. Edgar Fulmor, Peter S. Nichola, Pamela G. Alpin and Jarry M. Herron

    Version of Record online : 7 AUG 2009, DOI: 10.1002/clc.4960160407

  11. INHIBITION OF THE RENIN–ANGIOTENSIN SYSTEM ATTENUATES THE DEVELOPMENT OF LIVER FIBROSIS AND OXIDATIVE STRESS IN RATS

    Clinical and Experimental Pharmacology and Physiology

    Volume 35, Issue 2, February 2008, Pages: 159–167, Ebtehal El-Demerdash, Omar M Abdel Salam, Seham A El-Batran, Heba MI Abdallah and Nermeen M Shaffie

    Version of Record online : 27 SEP 2007, DOI: 10.1111/j.1440-1681.2007.04797.x

  12. Invasive Pharmacodynamics of Fosinopril in Patients with Congestive Heart Failure

    The Journal of Clinical Pharmacology

    Volume 35, Issue 8, August 1995, Pages: 785–793, Dr. Neville F. Ford, Mr. Chandra Natarajan, Mr. I. Edgar Fulmor, Dr. R. A. Smith and Dr. Ka Kit Hui

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1995.tb04121.x

  13. Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension

    Intervention Review

    The Cochrane Library

    Balraj S Heran, Michelle MY Wong, Inderjit K Heran and James M Wright

    Published Online : 8 OCT 2008, DOI: 10.1002/14651858.CD003823.pub2

  14. Disturbed colocalization of multidrug resistance protein 2 and radixin in human cholestatic liver diseases

    Journal of Gastroenterology and Hepatology

    Volume 23, Issue 7pt2, July 2008, Pages: e120–e128, Hideyuki Kojima, Shinya Sakurai, Masahito Uemura, Kensuke Kitamura, Hiroki Kanno, Yoshiyuki Nakai and Hiroshi Fukui

    Version of Record online : 28 AUG 2007, DOI: 10.1111/j.1440-1746.2007.05109.x

  15. Fosinopril

    Standard Article

    Handbook of Metabolic Pathways of Xenobiotics

    Lishan Lin

    Published Online : 1 OCT 2014, DOI: 10.1002/9781118541203.xen472

  16. You have free access to this content
    Purification of the human apical conjugate export pump MRP2

    European Journal of Biochemistry

    Volume 265, Issue 1, October (I) 1999, Pages: 281–289, Wolfgang Hagmann, Anne T. Nies, Jörg König, Manfred Frey, Hanswalter Zentgraf and Dietrich Keppler

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1432-1327.1999.00735.x

  17. Fosinopril Prevents the Development of Tactile Allodynia in a Streptozotocin-Induced Diabetic Rat Model

    Drug Development Research

    Volume 76, Issue 8, December 2015, Pages: 442–449, Claudia Ivonne Araiza-Saldaña, Erick Fabián Pedraza-Priego, Jorge Elías Torres-López, Héctor Isaac Rocha-González, Gabriela Castañeda-Corral, Enrique Hong-Chong and Vinicio Granados-Soto

    Version of Record online : 9 SEP 2015, DOI: 10.1002/ddr.21280

  18. You have free access to this content
    The ERM protein, Ezrin, regulates neutrophil transmigration by modulating the apical localization of MRP2 in response to the SipA effector protein during Salmonella Typhimurium infection

    Cellular Microbiology

    Volume 13, Issue 12, December 2011, Pages: 2007–2021, Terence A. Agbor, Zachary C. Demma, Karen L. Mumy, Jeffrey D. Bien and Beth A. McCormick

    Version of Record online : 28 SEP 2011, DOI: 10.1111/j.1462-5822.2011.01693.x

  19. Single-Dose and Steady-State Pharmacokinetics of Fosinopril and Fosinoprilat in Patients with Hepatic Impairment

    The Journal of Clinical Pharmacology

    Volume 35, Issue 2, February 1995, Pages: 145–150, Dr. Neville F. Ford, Dr. Kenneth C. Lasseter, Dr. Donald R. Van Harken, Dr. Janis L. Hammett, Mr. Ralph Raymond and Dr. James Manning

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1995.tb05003.x

  20. You have free access to this content
    Disposition of fosinopril sodium in healthy subjects.

    British Journal of Clinical Pharmacology

    Volume 25, Issue 1, January 1988, Pages: 9–15, SM Singhvi, KL Duchin, RA Morrison, DA Willard, DW Everett and M Frantz

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1988.tb03275.x